CDKN2A and melanoma: p16−/− mice (which retain p19/ARF) spontaneously develop and die from a variety of malignant tumors, including soft-tissue sarcoma, lymphoma, and melanoma [22], so the potential tumorigenic effects of p16 loss in the pancreas are not known.